149 related articles for article (PubMed ID: 37293900)
1. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
Kosnett MJ; Ma M; Dooley G; Wang GS; Friedman K; Brown T; Henthorn TK; Brooks-Russell A
Clin Toxicol (Phila); 2023 May; 61(5):355-362. PubMed ID: 37293900
[TBL] [Abstract][Full Text] [Related]
2. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking.
Rague JM; Ma M; Dooley G; Wang GS; Friedman K; Henthorn TK; Brooks-Russell A; Kosnett MJ
Clin Toxicol (Phila); 2023 May; 61(5):363-369. PubMed ID: 36939145
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
Fraser AD; Worth D
Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
[TBL] [Abstract][Full Text] [Related]
4. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
5. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
[TBL] [Abstract][Full Text] [Related]
6. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
7. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Liquid Chromatography High-Resolution Mass Spectrometry (LC-HRMS) Bioanalytical Method for Quantifying Cannabinoids in Whole Blood: Application for Determining Recent Cannabis Use.
DeGregorio MW; Audino SA; Montoya E; Phong A; Kao CJ; Wurz GT
J AOAC Int; 2020 Jun; 103(3):725-735. PubMed ID: 33241370
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
12. Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.
Wiegand DM; Methner MM; Grimes GR; Couch JR; Wang L; Zhang L; Blount BC
Ann Work Expo Health; 2020 Aug; 64(7):705-714. PubMed ID: 32219297
[TBL] [Abstract][Full Text] [Related]
13. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
Fraser AD; Worth D
Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
[TBL] [Abstract][Full Text] [Related]
15. Simulated driving performance among daily and occasional cannabis users.
Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
[TBL] [Abstract][Full Text] [Related]
16. Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers.
Hoffman MA; Hubbard JA; Sobolesky PM; Smith BE; Suhandynata RT; Sanford S; Sones EG; Ellis S; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
J Anal Toxicol; 2021 Sep; 45(8):851-862. PubMed ID: 34173005
[TBL] [Abstract][Full Text] [Related]
17. Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair.
Auwärter V; Wohlfarth A; Traber J; Thieme D; Weinmann W
Forensic Sci Int; 2010 Mar; 196(1-3):10-3. PubMed ID: 20129747
[TBL] [Abstract][Full Text] [Related]
18. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
[TBL] [Abstract][Full Text] [Related]
19. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
[TBL] [Abstract][Full Text] [Related]
20. THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?
Fabritius M; Favrat B; Chtioui H; Battistella G; Annoni JM; Appenzeller M; Dao K; Fornari E; Lauer E; Mall JF; Maeder P; Mangin P; Staub C; Giroud C
Drug Test Anal; 2014; 6(1-2):155-63. PubMed ID: 24173827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]